FRPT Stock Cash Flow Statements

Freshpet Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Freshpet Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31

cash flows from operating activities:
net income	16,356,000	-12,697,000	18,122,000	11,895,000	-1,694,000	18,602,000	15,290,000	-7,166,000	-16,952,000	-24,786,000	-2,917,000	-18,449,000	-20,586,000	-17,542,000					-3,297,894	3,547,032																			2,780,262	-1,675,350	-2,228,650	-2,587,074	-16,446,750
adjustments to reconcile net income to net cash flows from operating activities:
benefit from loss on accounts receivable	0	11,452,000		2,000																													-29,596	77,164
loss on disposal of property, plant and equipment	485,000	744,000	230,000	768,000	136,000	150,000
share-based compensation	6,221,000	8,816,000	13,945,000	12,107,000	19,534,000	6,221,000	-17,000	8,090,000	8,447,000	8,415,000	5,683,000	7,820,000	6,294,000	6,295,000	6,482,000	5,746,000	6,690,000	6,080,000	3,113,919	3,346,965	2,285,902	2,178,214	2,127,127	3,076,400	1,429,844	1,200,336	2,637,211	1,776,375	1,301,774	1,092,260	1,145,819	1,132,852	1,229,353	930,157									835,198
inventory obsolescence			-385,000	33,000	0	699,000				-29,000	0	0	3,604,000	-149,000	100,000	-4,000	124,000	129,000	85,170	-4,293	33,186	117,937	8,273	-546	94,932	10,238
depreciation and amortization	20,609,000	21,827,000	21,366,000	18,925,000	17,422,000	15,902,000	13,081,000	16,506,000	14,438,000	14,492,000	10,133,000	8,534,000	7,881,000	8,007,000	7,979,000	7,746,000	7,654,000	7,089,000	6,179,242	5,051,846	5,440,881	4,453,031	4,214,273	4,063,970	3,923,361	3,720,091	3,649,763	3,622,894	3,461,032	3,334,348	3,281,182	3,215,554	3,146,492	3,049,127	2,929,055	2,720,436	2,166,405	2,071,272	2,030,504	1,918,749	1,869,377	1,754,905	1,679,956
amortization of deferred financing costs	539,000	535,000
change in operating lease right of use asset	418,000	309,000	305,000	279,000	387,000	379,000	374,000	368,000	450,000	357,000	351,000	346,000	365,000	310,000	337,000	331,000
gain on equity investment			0	0	0	-9,918,000
changes in operating assets and liabilities:
accounts receivable	2,401,000	-5,609,000	-3,934,000	3,113,000	350,000	-11,757,000	-2,328,000	-2,527,000	-3,507,000	9,182,000	-10,590,000	13,865,000	-9,615,000	-26,653,000	-2,577,000	1,735,000	-5,151,000	-10,378,000	3,225,785	1,017,353									1,001,661	617,072				90,753					-16,133	-705,039	211,144	-1,172,276	-917,758
inventories	-6,448,000	-2,952,000	-6,632,000	-167,000	-868,000	-7,817,000	-434,000	6,206,000	1,021,000	-8,000,000	6,044,000	-3,655,000	-18,972,000	-9,588,000	-6,369,000	-4,704,000	-2,896,000	-2,835,000	-1,692,600	1,186,448							-637,504			190,775					1,149,596				86,475	971,325	-373,135	-118,939	-430,863
prepaid expenses and other current assets	-4,601,000	688,000	1,072,000	3,165,000	-4,516,000	548,000	-1,553,000	-266,000	-2,955,000	2,525,000	-1,509,000	-1,342,000	1,699,000	717,000	-1,751,000	303,000	-1,303,000	-140,000	-150,093	-594,341	10,171,569	9,865								284,943				275,711					65,925	394,098	29,603	572,122	-1,060,883
other assets	-1,958,000	-1,102,000	-3,523,000	-300,000	-549,000	-691,000	-558,000	267,000	-98,000	-3,664,000	-1,502,000	-1,281,000	632,000	-990,000	-2,379,000	-3,364,000	-2,293,000	137,000	-497,386	-9,860	-223,540	11,786								281,914									-34,104	-119,851	85,078	-130,025
accounts payable	-2,283,000	4,574,000	3,645,000	9,820,000	-10,890,000	9,909,000	1,243,000	9,788,000	3,236,000	-10,724,000	-4,493,000	1,851,000	-5,870,000	5,449,000	9,901,000	-10,437,000	9,246,000	6,248,000	-2,900,955	409,128	-4,085,861	655,688	-964,822			2,555,681	-995,756	-474,194			374,151	937,982	-2,431,847	3,801,808	282,466	-963,528	-239,766	1,774,682	-1,505,561	958,906	-738,088	1,477,326	-4,677,297
accrued expenses	2,503,000	-21,461,000	5,456,000	-3,714,000	23,012,000	-16,943,000	8,128,000	6,580,000	9,398,000	-4,869,000	8,452,000	139,000	6,298,000	-1,811,000	508,000	-2,150,000	3,170,000	-1,801,000	3,537,608	2,847,727			2,685,873								859,114	1,586,259			-189,128	-240,046	1,279,277	1,406,479
operating lease liability	-356,000	-317,000	-280,000	-350,000	-441,000	-396,000	-388,000	-382,000
net cash flows from operating activities	33,886,000	4,807,000	50,369,000	56,100,000	42,413,000	5,406,000	36,972,000								3,982,000				8,130,456				12,829,950				10,043,448	5,391,993			5,140,830			2,077,053	5,480,448	3,875,142	1,429,082	2,015,191	1,769,249	2,910,104	951,436	1,108,028
cash flows from investing activities:
acquisitions of property, plant and equipment, software and deposits on equipment	-33,441,000	-26,491,000	-58,264,000	-34,033,000	-48,322,000	-46,473,000	-77,451,000	-59,135,000	-44,468,000	-58,039,000	-62,634,000	-72,565,000	-38,984,000	-55,888,000	-101,264,000	-103,243,000	-68,258,000	-49,334,000	-34,644,113	-26,673,130																			-9,449,600	-7,530,180	-5,070,805	-4,964,527	-3,715,535
net cash flows used in investing activities	-33,441,000	-26,491,000	-58,264,000	-34,033,000	-48,322,000	-46,473,000	-77,451,000	54,306,000	-108,583,000	-107,365,000	-42,794,000	-72,564,000	-58,824,000	-59,182,000	-101,264,000	-103,243,000	-68,258,000	-49,334,000	-24,913,612	-44,296,435																			-8,990,587	-3,755,571	-10,050,515	-12,463,732	-3,624,068
cash flows from financing activities:
tax withholdings related to net shares settlements of restricted stock units	1,000	-2,861,000	-1,155,000	0	-1,217,000	-223,000	-541,000	-9,000	-248,000	-602,000	-162,000	-66,000	-890,000	-323,000	-989,000	-281,000	-1,388,000	-1,529,000	-931,704	0
principal payments under finance lease obligations	-524,000	-513,000	-533,000	-492,000	-450,000	-502,000	-561,000
proceeds from exercise of options to purchase common stock	30,000	157,000	3,622,000	1,320,000	1,381,000	2,815,000	345,000	1,111,000	2,227,000	834,000	142,000	0	97,000	232,000	223,000	308,000	1,026,000	714,000	777,544	2,572,920	1,687,980	402,556	618,527	66,370	1,983,880	1,791,668
net cash flows from financing activities	-493,000	-3,217,000	1,934,000	828,000	-286,000	2,090,000	-757,000	554,000	1,979,000	325,513,000	-75,234,000	-3,193,000	364,056,000	50,909,000	-766,000	26,000	-806,000	328,539,000	-154,882	2,572,921	-127,250	196,753,211	19,330,475	6,980,358	18,804,842	11,117,894	-1,746,687	72,594	-1,310,799	6,053,862	-2,857,691	-176,803			-1,213,071	2,747,910	8,222,186	10,970	-1	49,294	227,496	14,960	42,667,253
net change in cash and cash equivalents	-48,000	-24,901,000	-5,961,000	22,895,000	-6,195,000	-38,977,000	-41,236,000	94,059,000	-93,095,000	204,408,000	-107,575,000	-67,035,000	277,615,000	-43,058,000	-98,048,000	-109,487,000	-60,644,000	273,720,000	-16,938,038	-23,543,171	-41,758,274	140,014,483					4,704,325			855,082									-7,221,339	-796,173
cash and cash equivalents, beginning of year	0	268,633,000	0	0	0	296,871,000	0	0	0	132,735,000	0	0	0	72,788,000	0	0	0	67,247,000	324	0	0	9,471,676	0	0	0	7,554,388	0	0	0	2,184,259	0	0	0	3,908,177	0	0	0	8,029,413	0	0
cash and cash equivalents, end of period	-48,000	243,732,000	-5,961,000	22,895,000	-6,195,000	257,894,000	-41,236,000	94,059,000	-93,095,000	337,143,000	-107,575,000	-67,035,000	277,615,000	29,730,000	-98,048,000	-109,487,000	-60,644,000	340,967,000	-16,937,714	-23,543,171	-41,758,274	149,486,159	2,265,941	2,452,899	991,553	3,761,283	4,704,325	1,715,778	-1,905,056	3,039,341	114,915	1,394,160	-1,348,604	2,023,788	411,864	1,777,224	1,452,960	266,129	-7,221,339	-796,173
supplemental cash flow information:
interest paid, net of amounts capitalized	47,000	5,945,000
operating right-of-use assets obtained in exchange for lease obligations
non-cash financing and investing activities:
property, plant and equipment and software purchases in accounts payable and accrued expenses	1,268,000	7,789,000
non-cash addition of finance lease to property, plant and equipment	0	7,236,000					0
tax withholdings related to net shares settlements of restricted stock units in accrued expenses	243,000	58,000		84,000	-1,140,000	1,859,000
benefit from loss (gains) on accounts receivable						4,000		1,000	10,000	-2,000		-9,000	11,000	-25,000	14,000
write-off and amortization of deferred financing costs and loan discount			530,000	524,000	521,000	514,000	512,000	514,000	556,000	2,478,000
loss on equity method investment							0	0	910,000	980,000	762,000	942,000	717,000	1,310,000	881,000
purchase of short-term investments							0	0	-64,115,000	-49,326,000	0	0							1,196	0
proceeds from maturities of short-term investments							0												9,998,804																0	0	0	3,250,000	499,205
investments in equity method investment											0	1,000	0	-3,294,000			349,000	236,000	-269,499
purchase of capped call options
proceeds from issuance of convertible senior notes							0	0	0	393,518,000
debt issuance costs							0	0	0	-2,026,000
proceeds from borrowings under credit facility											0	0	27,000,000	51,000,000
repayment of borrowings under credit facility											-75,214,000
proceeds from common shares issued in primary offering, net of issuance cost											0	-341,000			0	0	-348,000	332,520,000	-254	1	-1	252,062,254
interest paid				6,601,000	574,000	6,591,000	612,000	7,474,000	1,000	1,216,000	0	1,887,000	844,000	421,000	442,000	449,000	631,000	208,000	135,604	135,979	22,467	766,950	0	355,844	136,127	29,717	20,217	59,438	67,471	37,293	29,542	193,622	141,951	154,165	81,286	232,689	126,302	5,000	156,667	75,833	75,000	24,744	1,776,634
property, plant and equipment purchases in accounts payable and accrued expenses				-7,155,000	-2,839,000	17,332,000	-3,744,000	-11,769,000	8,856,000	25,943,000
amortization of discount on short-term investments
capitalized interest in accrued expenses
receivable from exercise of options to purchase common stock										1,120,000
benefit from (gains) loss on accounts receivable
fees paid in connection with financing agreements																-1,000	-96,000	-3,166,000
taxes paid
issuance of partner warrants											0
loss on disposal of equipment								224,000	196,000	268,000	193,000	114,000	46,000	43,000	254,000	178,000	46,000	60,000	504,481	1,264,664	34,193	1,662	648,922	137,422	-7,344	8,028
repayment of borrowings under credit facilities																			0	0
purchase of capped call option								0	0	-66,211,000
adjustments to reconcile net income to net cash flows used in operating activities:
net cash flows used in operating activities									13,509,000	-13,740,000		8,722,000	-27,617,000	-34,785,000				-5,485,000																									-4,542,135
other lease liabilities										-363,000	-356,000	-351,000	-387,000	-290,000	-331,000	-328,000	-298,000	-345,000	-356,130	-441,086
amortization of deferred financing costs and loan discount											199,000	198,000	266,000	132,000	199,000	198,000	198,000	617,000	71,445	71,088	66,168	625,299	85,562	53,009	43,519	28,775	28,776	28,776	28,776	28,775	27,886	317,146	40,751	40,751	40,594	37,609	36,168	35,901	35,862	37,987	35,680	35,294
property, plant and equipment purchases in accounts payable												-4,313,000	-31,773,000	51,572,000		-15,894,000	-1,043,000	19,536,000	8,610,633	1,243,244	-7,244,567	8,671,690	1,792,600	-1,880,522	7,198,891	463,546	278,176	-123,559	-350,353	1,046,377	508,969	-272,616	-677,214	1,447,039	932,188	-760,381	393,027	839,716	1,458,425	-1,397,661	654,527	1,320,823
net																	-7,476,000	-10,888,000
adjustments to reconcile net (loss) to net cash flows from operating activities:
proceeds from borrowings under credit facilities																			0	0	0	20,933,000	21,670,111	15,313,988	25,307,000	10,000,000	0	0	0	6,000,000	0	5,500,000			0
financing fees paid in connection with borrowings																			-468	0
non-cash acquisitions of property, plant and equipment																										1,749,901
net cash flows from (used in) operating activities
benefit from loss/(gains) on accounts receivable																		-3,000	-19,174	-10,457	-84,081	90,712	-89,689			28,778				5,232	-13,605
operating lease right of use																		309,000	327,038	498,129	155,793	308,040	306,130			241,785
other current liabilities
conversion of warrants to common stock																															0
changes in operating assets and liabilities
prepaid expenses, other non-trade receivables and other current assets
loss on disposal of equipment and deposits on equipment																											37,390	28,508	48,382	27,879	6,024	6,819	84,868	6,005	19,734	11,185	15,205	143,407	10,277	2,643	71,956	8,723	161,870
fair value adjustment for outstanding warrants																															0	-44,053							-97,543	-475,246	-43,943	114,106
change in reserve for inventory obsolescence																											29,383	838	16,351	52,723	-23,108	210,434	22,647	81,925		-14,531	-5,062	133,174	-137,899	37,908	-11,037	6,006	-17,667
other liabilities																															67,961
proceeds from sale of equipment																																		5,835	929	1,841	5,000	5,672	1,557				91,467
exercise of options to purchase common stock																											253,313	2,072,594	945,427	53,862	2,667,903	2,068,488	2,990,848	553,221	786,929	1,747,910	222,186	10,970	-1	49,294	227,496	14,960
purchase of treasury shares
non-cash investing and financing activities:
purchase of stock for tax withholding
purchases of short-term investments																																							0	0	0	-7,499,205
acquisitions of land and building																																							-41,749	-4,791
net cash flows (used in) investing activities
benefit from (gain)/loss on accounts receivable
fees on debt guarantee																																											15,475,777
borrowings on long-term debt
repayment of long-term debt
proceeds from preferred stock - series c issued
redemption of series b preferred stock
proceeds from shares of common stock issued in initial public offering, net of issuance costs
preferred stock dividend accretion of series c and series b preferred stock and additional loss upon conversion of series c preferred stock into common stock upon consummation of ipo
benefit from gains on accounts receivable
share based compensation																																				787,676	1,665,372	1,006,046	-1,566,233	1,825,640	1,804,338	1,860,112
benefit from losses on accounts receivable																																									24,919	-918	-212,636
proceeds from borrowings under line of credit
benefit from losses (gains) on accounts receivable																																						7,805
accrued expenses and accrued interest on long-term debt																																							102,648	-234,881	214,194	-711,334	-1,606,073
proceeds from the issuance of shares of common stock in private placement
benefit from (gains) losses on accounts receivable
preferred stock dividend accretion
net change in cash and equivalents																																										-11,340,744	34,501,050
cash and equivalents, beginning of year																																										36,259,252	0
cash and equivalents, end of period																																										24,918,508	34,501,050
·
revaluation of outstanding warrants
issuance of common stock options for services
proceeds from issuance of series c preferred stock
effect of exchange rate changes on cash
amortization of loan discount and deferred financing costs
other assets and deferred offering costs
borrowings on notes payable
financing fees paid in connection with note payable
proceeds from issuance of preferred stock—series c
non-cash financing activity:

We provide you with 20 years of cash flow statements for Freshpet stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Freshpet stock. Explore the full financial landscape of Freshpet stock with our expertly curated income statements.

The information provided in this report about Freshpet stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.